PharmaPendium resources and support
Find links to PharmaPendium factsheets, and upcoming and recorded webinars. Access Support Hub resources to help onboard users through the quick links box.
![Woman looking at PharmaPendium's home screen](http://images.ctfassets.net/o78em1y1w4i4/4ohM0FMdCf3ySpSUp19Kvt/99a65800500635ffc43acc05934b33f6/iStock-850852928_v5-crop-header.jpg?fm=webp&w=2280&q=75)
Fact sheets
Webinars
How DDI predictions using a static approach can support FDA and EMA drug submission and labelling새 탭/창에서 열기, Olivier Barberan, Director of Translational Medicine Solutions, Elsevier
Better support for first-in-human dosing with PharmaPendium새 탭/창에서 열기, Thomas Vargues, Product Manager, Elsevier
Improving clinical trial strategy and efficiency with PharmaPendium’s Efficacy Module새 탭/창에서 열기, Pooja Jain, Senior Product Manager, Elsevier
COVID-19 search strategies in PharmaPendium: Focus on drug safety and efficacy새 탭/창에서 열기, Thomas Vargues, PhD, Product Manager, and Marnix Wieffer, PhD, Marketing Manager, PharmaPendium
COVID-19 search strategies in PharmaPendium: Focus on DMPK data and predicting drug-drug interactions새 탭/창에서 열기, Thomas Vargues, PhD, Product Manager, and Marnix Wieffer, PhD, Marketing Manager, PharmaPendium
Model-based strategy to guide the choice of clinical doses for ADC새 탭/창에서 열기, Julie Desrivot Quénelle, PKPD Project Lead at Pierre Fabre
Customer insights
Enabling comprehensive assessments of drug–drug interaction risks새 탭/창에서 열기, Dr. Kevin Lustig, president and CEO of The Assay Depot, Inc., and dr. Maria Thompson, principal consultant
Making more informed drug development decisions새 탭/창에서 열기, Laura Newman, DMPK scientist
The model of intelligence새 탭/창에서 열기, Dr. Chris Penland, senior expert modeler at Novartis
Streamlining preclinical and clinical drug development새 탭/창에서 열기, Scientific information manager, leading dermatology company
Fast and comprehensive assessments of drug-drug interaction risk새 탭/창에서 열기, Senior researchers, global biopharmaceutical company